Transcode Therapeutics Inc (RNAZ)

Apr 13, 2026

Aug Weekly: Is TransCode Therapeutics Inc showing insider buying2026 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

RNAZ Stock Price, Quote & Chart | TRANSCODE THERAPEUTICS INC (NASDAQ:RNAZ) - ChartMill

Apr 10, 2026

Apr 10, 2026

Geopolitics Watch: Can TransCode Therapeutics Inc sustain its profitability - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

TransCode Therapeutics signs financing deal worth up to $20 million - MSN

Apr 09, 2026

Apr 08, 2026

Chipmakers Recap: Is TransCode Therapeutics Inc a good stock for dollar cost averaging2026 Macro Moves & Weekly Setup with ROI Potential - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Aug Big Picture: What is TransCode Therapeutics Incs P E ratio telling us2026 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Insider Sell: Why is TransCode Therapeutics Inc stock going downEarnings Growth Report & Stock Portfolio Risk Management - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

TransCode Therapeutics Secures New Financing to Extend Runway - The Globe and Mail

Apr 08, 2026

Apr 07, 2026

TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028 - Bitget

Apr 07, 2026

Apr 07, 2026

TransCode Therapeutics Secures Up to $20 Million Financing for Metastatic Cancer Trial - citybuzz -

Apr 07, 2026

Apr 07, 2026

TransCode Therapeutics Secures Up to $20 Million Flexible Financing to Advance Lead Cancer Program and Extend Runway Into 2028 - Minichart

Apr 07, 2026

Apr 07, 2026

Eightco (NASDAQ: ORBS) Represents the Biggest Public Market Exposure to OpenAI for Retail Investors - Weekly Voice

Apr 07, 2026

Apr 07, 2026

TransCode Therapeutics Secures $20M Financing - citybiz

Apr 07, 2026

Apr 07, 2026

Transcode Therapeutics Secures Up To $14 Million Standby Equity Facility and $6 Million Notes With Yorkville - TradingView — Track All Markets

Apr 07, 2026

Apr 07, 2026

TransCode Therapeutics (NASDAQ: RNAZ) lines up up to $20M in new flexible funding - Stock Titan

Apr 07, 2026

Apr 07, 2026

TransCode lands $20M to keep its cancer trial funded into 2027 - Stock Titan

Apr 07, 2026

Apr 06, 2026

Market Overview: How sensitive is TransCode Therapeutics Inc to inflationWeekly Risk Summary & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Form 8-KCurrent report - ADVFN

Apr 06, 2026

Apr 05, 2026

Responsive Playbooks and the RNAZ Inflection - Stock Traders Daily

Apr 05, 2026

Apr 04, 2026

RNAZ PE Ratio & Valuation, Is RNAZ Overvalued - Intellectia AI

Apr 04, 2026

Apr 02, 2026

TransCode Therapeutics, Inc. (RNAZ) Competitors - Meyka

Apr 02, 2026

Apr 01, 2026

TransCode Therapeutics Delays 2025 Annual Filing - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Bank Watch: Is TransCode Therapeutics Inc attractive for institutional investorsTrade Analysis Report & Low Risk Growth Stock Ideas - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Is TransCode Therapeutics Inc attractive for institutional investorsWeekly Profit Report & Safe Capital Growth Plans - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

RNAZ (RNAZ) delays 2025 Form 10-K after $25M preferred placement and acquisition - Stock Titan

Mar 31, 2026

Mar 30, 2026

Growth Value: Is TransCode Therapeutics Inc showing insider buying2026 Review & Community Trade Idea Sharing Platform - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Gap Down: Is TransCode Therapeutics Inc subject to activist investor interestAnalyst Upgrade & Fast Moving Stock Watchlists - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Aug Volume: What are analysts price targets for TransCode Therapeutics IncDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Aug Mood: Does TransCode Therapeutics Inc have pricing power2026 Pullbacks & Intraday High Probability Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 25, 2026

Bond Watch: Whats the outlook for TransCode Therapeutics Incs sector2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Understanding the Setup: (RNAZ) and Scalable Risk - Stock Traders Daily

Mar 25, 2026

Mar 21, 2026

Portfolio Update: Will TransCode Therapeutics Inc benefit from sector rotation2026 Institutional Moves & High Win Rate Trade Tips - baoquankhu1.vn

Mar 21, 2026

Mar 19, 2026

Is TransCode Therapeutics Inc undervalued by DCF analysis2026 Spike Watch & Verified Swing Trading Watchlists - baoquankhu1.vn

Mar 19, 2026

Mar 19, 2026

Breakout Zone: Should I hold or sell TransCode Therapeutics Inc now2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Aug Chart Watch: Is TransCode Therapeutics Inc showing insider buyingWeekly Profit Summary & Momentum Based Trading Ideas - baoquankhu1.vn

Mar 18, 2026

Mar 14, 2026

The Technical Signals Behind (RNAZ) That Institutions Follow - Stock Traders Daily

Mar 14, 2026

Mar 07, 2026

RNAZ Should I Buy - Intellectia AI

Mar 07, 2026

Mar 07, 2026

How interest rate cuts could boost TransCode Therapeutics Inc. stockWeekly Profit Analysis & Safe Swing Trade Setup Alerts - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Bank Watch: Is TransCode Therapeutics Inc a good ESG investmentJuly 2025 Decliners & Risk Managed Investment Signals - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Aug Macro: Can TransCode Therapeutics Inc disrupt its industryJuly 2025 Chart Watch & Real-Time Stock Movement Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Aug Weekly: Is TransCode Therapeutics Inc a speculative investmentTrend Reversal & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138 - Revista ADVFN

Mar 06, 2026

Mar 05, 2026

TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits

Mar 05, 2026

Mar 04, 2026

TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal - The Globe and Mail

Mar 04, 2026

Mar 03, 2026

TransCode Therapeutics (NASDAQ: RNAZ) adds Unleash oncolytic platform in all-stock licensing deal - Stock Titan

Mar 03, 2026

Mar 03, 2026

TransCode licenses bladder cancer therapy platform from Unleash - Investing.com

Mar 03, 2026

Mar 03, 2026

Precision Trading with Transcode Therapeutics Inc. (RNAZ) Risk Zones - Stock Traders Daily

Mar 03, 2026

Mar 03, 2026

TransCode Therapeutics Incenters exclusive license agreement with Unleash - marketscreener.com

Mar 03, 2026

Mar 03, 2026

TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of - PR Newswire

Mar 03, 2026

Mar 02, 2026

RNAZTransCode Therapeutics Announces Strategic Expansion of its Product Portfolio - mx.advfn.com

Mar 02, 2026

Feb 28, 2026

RNAZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026

Feb 27, 2026

TransCode Therapeutics Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules - mx.advfn.com

Feb 27, 2026

Feb 26, 2026

TransCode Therapeutics (NASDAQ:RNAZ) Shares Up 0.8% – Still a Buy? - Defense World

Feb 26, 2026

Feb 25, 2026

Fed Watch: Is TransCode Therapeutics Inc showing insider buyingPortfolio Risk Summary & Weekly Setup with High ROI Potential - baoquankhu1.vn

Feb 25, 2026

Feb 25, 2026

Buyout Rumor: Why is TransCode Therapeutics Inc stock going downEarnings Overview Report & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 25, 2026

Feb 25, 2026

Aug Gainers: Is TransCode Therapeutics Inc subject to activist investor interestMarket Growth Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Feb 25, 2026

Feb 23, 2026

TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy - TipRanks

Feb 23, 2026

Feb 23, 2026

TransCode Therapeutics publishes preclinical RIG-I agonist study showing tumor-selective activation, supports TTX platform - TradingView

Feb 23, 2026

Feb 23, 2026

TransCode Therapeutics (RNAZ) highlights RIG-I cancer immunotherapy study in 8-K - Stock Titan

Feb 23, 2026